Therapeutic and diagnostic methods using soluble T cell surface

Details Therapeutic and diagnostic methods using soluble T cell surface Therapeutic and diagnostic methods using soluble T cell surface

1987-03-02

1991-04-09

Kepplinger, Esther L.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

435 723, 435810, 435 724, 435975, 436501, 436506, 436510, 436518, 436536, 436548, 436811, 436813, 530395, 530806, 935110, G01N 33566, G01N 33569, G01N 33574, G01N 33577

Patent

active

050064592

ABSTRACT:
The present invention is directed to the measurement of soluble T cell growth factor receptors, soluble T cell differentiation antigens, or related soluble molecules or fragments thereof, and the use of such measurements in the diagnosis and therapy of diseases and disorders. The measurement of such molecules can be valuable in monitoring the effect of a therapeutic treatment on a subject, detecting and/or staging a disease in a subject, and in differential diagnosis of a physiological condition in a subject. These measurements can also aid in predicting therapeutic outcome and in evaluating and monitoring the immune status of patients.
In specific embodiments, measurements of serum or plasma interleukin-2 receptor levels can be made, to detect or stage leukemia or lymphoma. In other embodiments, IL2R levels, or CD8 levels, can be used to differentially diagnose renal allograft rejection, as distinguished from Cyclosporin A nephrotoxicity. In another embodiment, CD8 levels can be measured to differentially diagnose rheumatoid arthritis, as distinct from other joint diseases.
In particular embodiments, measurements of the soluble T cell surface molecules can be accomplished by sandwich enzyme immunuoassays.

REFERENCES:
patent: 4376110 (1983-03-01), David et al.
patent: 4707443 (1987-11-01), Nelson et al.
Fujimoto et al., Journ. Exp. Med., 159, 752-766, 1983.
Fujimoto et al., Journ. Exp. Med., 160, 116-124, 1984.
Greene et al., Ann. Intern. Med., 105, 560-572, 1986.
MacKeen et al., Fed. Proc., 45, p. 454, Abs. No. 1746 (1986).
Nelson, Fed. Proc., 45, p. 377, Abs. No. 1294 (1986).
Rubin et al., Clin. Res., 33, 457A, (1985).
Rubin et al., Journ. Immunol., 135, 3172-3177 (1985).
Rubin et al., Leukocytes and Most Defense, Alan R. Liss, Inc., New York, 1986, pp. 95-102.
Snow et al., Journ. Biol. chem., 260, 2700-2708, 1985.
Kung et al., Science 206:347-349 (1979).
Reinherz et al., Proc. Natl. Acad. Sci. U.S.A. 76:4061-4065 (1979).
Reinherz et al., Proc. Natl. Acad. Sci. U.S.A. 77:1588-1592 (1980).
Verbi et al., Eur. J. Immunol. 12:81-86 (1982).
Kanellopoulos et al., The EMBO J. 2:1807-1814 (1983).
Kung et al., Int. J. of Dermatol. 22:67-74 (1983).
Krensky and Clayberger, Transplantation 39:339-348 (1985).
McDougal et al., Science 231:382-385 (1986).
Miller et al., Blood 68(1):78-86 (1981).
Falcao et al., J. Clin. Lab. Immunol. 13:141-143 (1984).
Oh et al., Scan. J. Immunol. 22:51-60 (1985).
Acuto et al., Cell 34:717-726 (1983).
Brenner et al., J. Exp. Med. 160:541-551 (1984).
Meuer et al., Proc. Natl. Acad. Sci. U.S.A. 81:1509-1513 (1984a).
Meuer et al., Ann. Rev. Immunol. 2:23-50 (1984b).
McKenzie and Parish, J. Exp. Med. 144:847-851 (1976).
Parish et al., Immunogenetics 3:129-137 (1976).
Parish and McKenzie, Cellular Immunol. 33:134-144 (1977).
Parish et al., Infection and Immunity 26:422-426 (1979).
Wilson et al., J. Immunol. 122:1967-1971 (1979).
Sandrin et al., J.N.C.I. 66:279-283 (1981).
Mier and Gallo, Proc. Natl. Acad. Sci. U.S.A. 77:6134-6138 (1980).
Smith, Immunol. Rev. 51:337-357 (1980).
Arya et al., Science 223:1086-1087 (1984).
Lotze et al., J. Immunol. 135:2865-2875 (1985).
Touw et al., Blood 66:556-561 (1985).
Robb et al., J. Exp. Med. 154:1455-1474 (1981).
Uchiyama et al., J. Immunol. 126:1393-1397 (1981).
Leonard et al., Nature 300:267-269 (1982).
Korsmeyer et al., Proc. Natl. Acad. Sci. U.S.A. 80:4522-4526 (1983).
Depper et al., J. Immunol. 133:1691-1695 (1984).
Sugamura et al., Proc. Natl. Acad. Sci. U.S.A. 81:7441-7445 (1984).
Tsudo et al., J. Exp. Med. 160:612-617 (1984).
Waldmann et al., J. Exp. Med. 160:1450-1466 (1984).
Dower et al., J. Exp. Med. 162:501-515 (1985).
Ebert et al., Clin Immunol. and Immunopathol. 37:283-297 (1985).
Rubin et al., Hybridoma 4:91-102 (1985).
Uchiyama et al., J. Clin. Invest. 76:446-453 (1985).
Greene and Leonard, Ann. Rev. Immunol. 4:69-95 (1986).
Gupta, Clin. Immunol. and Immunopathol. 38:93-100 (1986).
Mutsuoka et al., Leukemia Res. 10:597-603 (1986).
Tsudo et al., Blood 67:316-321 (1986).
Tuow et al., Blood 68:1088-1094 (1986).
Chilosi et al., Int. J. Biological Markers 2:101-104 (1986).
Durno et al., Blood 68 Suppl. #1, 124a (1986).
John et al., Sixth Int. Cong. Immunol. Toronto, Canada (1986).
Keller et al., Am. Diabetes Assoc. (1986).
Nelson et al., Pediatric Res. 20:136-139 (1986).
Pizzolo et al., Blood 68 Suppl. #1, 228a (1986).
Reuben et al., Blood 68 Suppl. #1, 213a (1986).
Rubin et al., J. Immunol. 137:3841-3844 (1986).
Saadeh et al., Fed. Proc. 45:378 (1986).
Treiger et al., J. Immunol. 136:4099-4105 (1986).
van Es et al., Transplantation 37:65-69 (1984).
Austen and Cosimi, N. Engl. J. Med. 311:1436-1438 (1984).
Hancock et al., Transplantation 39:430-438 (1985).
Magrath et al., Blood 63:1102-1111 (1984).
Pui et al., Blood 66:778-782 (1985).
Murphy et al., J. Clin. Oncol. 4:1732-1739 (1986).
Arseneau et al., Am. J. Med. 58:314-321.

Affiliated with

Also associated with

Rating

Therapeutic and diagnostic methods using soluble T cell surface does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic and diagnostic methods using soluble T cell surface , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic and diagnostic methods using soluble T cell surface will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2034152